How does labetalol affect the management of hypertension in patients with metabolic syndrome and what are the long-term implications?
Lakshya KumarExplorer
Sign Up to our social questions and Answers Engine to ask questions, answer people’s questions, and connect with other people.
Please briefly explain why you feel this question should be reported.
Please briefly explain why you feel this answer should be reported.
Please briefly explain why you feel this user should be reported.
Labetalol effectively lowers blood pressure in metabolic syndrome by blocking alpha and beta receptors, reducing risks of cardiovascular complications. Long-term, it may improve arterial stiffness and endothelial function.